IIL is a leading manufacturer of human and animal vaccines in India and other global markets. Dr K Anand Kumar, MD, Indian Immunologicals Ltd (IIL) divulges details about his company's growth plans for the future, its current R&D pipeline, trends in vaccine development, IIL's role in India Immunisation Programme and more, in an interaction with Lakshmipriya Nair
Can you give us an overview of the competitive landscape in the vaccines market, in India and globally? What is IIL’s market share of the total pie?
The total size of the human domestic trade market in India is about $333 million and is dominated by multinational companies such as GSK, Sanofi and Pfizer. The domination is on account of vaccines which are not supplied by Indian companies such as pneumococcal vaccine, HPV, Varicella etc. The top three brands in the trade market are Synflorix (pneumococcal vaccine by GSK), Hexaxim (hexavalent vaccine by Sanofi) and Prevenar 13 (pneumococcal vaccine by Pfizer). The three together command 22 per cent of the market size. The higher sales figure is on account of the higher price of the vaccine sold by the MNCs and not based on the units consumed.
The situation is different in India where an Indian company makes a vaccine. IIL is the leader in anti-rabies vaccine segment, Biological Evans is the leader in TT, Bharat Biotech is the leader in Typhoid Conjugate vaccine. IIL holds 36 per cent of the market share in the anti-rabies vaccine segment. Several Indian companies have a growing list of vaccines in their R&D pipeline and in the years to come the present dominance of the MNCs will be dented for sure.
In addition to the human domestic trade market, the government procures vaccines worth $250 million.
Total veterinary vaccine market in India, which includes the domestic trade market and government business, is $133 million. 60 per cent of that is for the poultry segment. IIL holds 53 per cent of the market share in the served market and 23 per cent in the overall market.
In the days to come, what will be the major drivers which will define the vaccine market in both, veterinary biologicals and human vaccines?
Diese Geschichte stammt aus der August 16-31, 2019-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der August 16-31, 2019-Ausgabe von Express Pharma.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation